Solid Biosciences INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
DEFA14A: Solid Biosciences Inc. to Hold Annual Meeting, Seeks Stockholder Approval for Key Proposals
Solid Biosciences Inc. is holding its annual meeting on June 12, 2025, seeking stockholder votes on director elections, auditor ratification, and amendments to the company's certificate of incorporation and equity incentive plan.
NASDAQ
Solid Biosciences is asking stockholders to approve an increase in authorized common stock and an amendment to its equity incentive plan at the 2025 annual meeting.
NASDAQ
Solid Biosciences is holding its annual meeting on June 11, 2024, seeking stockholder approval for several key proposals, including increasing authorized shares and expanding the equity incentive plan.
NASDAQ
Solid Biosciences is asking stockholders to vote on proposals to increase authorized common stock and amend its equity incentive plan at the upcoming annual meeting.